Understanding Tumor Microenvironment | Using Omics Platforms to Assign Treatment
00:00:29

Understanding Tumor Microenvironment | Using Omics Platforms to Assign Treatment

Eric Jonasch, MD, UT MD Anderson Cancer Center explains Understanding Tumor Microenvironment | Using Omics Platforms to Assign Treatment at Annual Meeting 2018

107 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Latest Videos

Supportive Care Video Series 2019 - Chemotherapy Induced Peripheral Neuropathy
0:30:03

Supportive Care Video Series 2019 - Chemotherapy Induced Peripheral Neuropathy
3 Views
1 day ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
CHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma

CHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma
7 Views
1 day ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Standard Conversion Rate From Lumpectomy to Mastectomy
0:03:13

Standard Conversion Rate From Lumpectomy to Mastectomy
2 Views
1 day ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Reducing The Need For Second Surgery After Lumpectomy: How Will This Affect Data Today?
0:01:59

Reducing The Need For Second Surgery After Lumpectomy: How Will This Affect Data Today?
0 Views
1 day ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Cancer Patients Have Limited Understanding of Genomic Test Results

Cancer Patients Have Limited Understanding of Genomic Test Results
13 Views
2 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Reducing The Need For Second Surgery After Lumpectomy: Why Isn't Everybody Doing This?
0:02:47

Reducing The Need For Second Surgery After Lumpectomy: Why Isn't Everybody Doing This?
2 Views
2 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Phase III CASPIAN Trial IMFINZI: The Full Trial Design
0:02:20

Phase III CASPIAN Trial IMFINZI: The Full Trial Design
3 Views
2 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Exciting Advances in SCLC
0:02:35

Exciting Advances in SCLC
3 Views
2 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Is the Phase III CASPIAN trial IMFINZI practice changing?
0:02:52

Is the Phase III CASPIAN trial IMFINZI practice changing?
2 Views
2 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
IMFINZI in the Phase III CASPIAN trial
0:02:14

IMFINZI in the Phase III CASPIAN trial
3 Views
2 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Intraoperative Teamwork of Breast Cancer Surgeon and Pathologist
0:02:20

Intraoperative Teamwork of Breast Cancer Surgeon and Pathologist
4 Views
2 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
How does this affect treatment?
0:01:40

How does this affect treatment?
4 Views
3 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Acute Lymphoblastic Leukemia

What is PFS2 in Advanced NSCLC, and Should we Care_ Unique Analysis of the KEYNOTE-024 trial [720p] - OncologyTube
EE:EE:EE

What is PFS2 in Advanced NSCLC, and Should we Care_ Unique Analysis of the KEYNOTE-024 trial [720p] - OncologyTube
17 Views
6 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit

Patient Priorities Should be Paramount when Measuring Quality in Cancer Care According to Panelists at NCCN Policy Summit
10 Views
1 week ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
IASLC World Conference on Lung Cancer—Press Briefing Summary from Sunday, September 8th in Barcelona

IASLC World Conference on Lung Cancer—Press Briefing Summary from Sunday, September 8th in Barcelona
15 Views
1 week ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
IPS based approach for treating virus-induced tumors

IPS based approach for treating virus-induced tumors
6 Views
1 week ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Pivotal New Data from Merck’s Broad Oncology Portfolio at ESMO 2019 Congress

Pivotal New Data from Merck’s Broad Oncology Portfolio at ESMO 2019 Congress
16 Views
1 week ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
AMGEN ANNOUNCES NEW CLINICAL DATA EVALUATING NOVEL INVESTIGATIONAL KRASG12C INHIBITOR IN LARGER PATIENT GROUP AT WCLC 2019

AMGEN ANNOUNCES NEW CLINICAL DATA EVALUATING NOVEL INVESTIGATIONAL KRASG12C INHIBITOR IN LARGER PATIENT GROUP AT WCLC 2019
14 Views
1 week ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Soricimed and Image Analysis Group Partner to Validate Predictive Imaging Markers for SOR-C13 Treatment Response in Solid Cancer Tumors

Soricimed and Image Analysis Group Partner to Validate Predictive Imaging Markers for SOR-C13 Treatment Response in Solid Cancer Tumors
12 Views
2 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Intraoperative Teamwork of Breast Cancer Surgeon and Pathologist Greatly Reduces Need for Second Surgery After Lumpectomy

Intraoperative Teamwork of Breast Cancer Surgeon and Pathologist Greatly Reduces Need for Second Surgery After Lumpectomy
20 Views
2 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Sysmex Inostics publishes first feasibility study of NGS-based liquid biopsy to complement early breast cancer screening by imaging

Sysmex Inostics publishes first feasibility study of NGS-based liquid biopsy to complement early breast cancer screening by imaging
14 Views
2 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Will advances in AI lead to more effective screening practices for ovarian cancer?

Will advances in AI lead to more effective screening practices for ovarian cancer?
11 Views
2 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Cancer doctors don't focus on lifestyle risks

Cancer doctors don't focus on lifestyle risks
12 Views
2 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Entresto improved measures of heart structure and function in HFrEF patients in new Novartis study; additional data complement findings

Entresto improved measures of heart structure and function in HFrEF patients in new Novartis study; additional data complement findings
30 Views
2 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Acute Myelogenous Leukemia

How to Manage MDS Patients who are Ineligible for Transplant
00:01:47

How to Manage MDS Patients who are Ineligible for Transplant
294 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The Recent Wave of Approval in AML
00:01:54

The Recent Wave of Approval in AML
134 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Updated Data on Gilteritinib in AML
00:01:12

Updated Data on Gilteritinib in AML
13 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Latest Data on Uproleselan with Chemotherapy
00:01:16

Latest Data on Uproleselan with Chemotherapy
94 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
AML Case: A 54-year-old woman is in remission but MRD+
00:19:28

AML Case: A 54-year-old woman is in remission but MRD+
110 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Update: New Drugs for AML
00:20:43

Update: New Drugs for AML
169 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Hypomethylating Agents In Myeloid Disorders: Lower Doses Of Decitabine And Azacitidine Have Proven As Effective As Standard Dosing
00:02:42

Hypomethylating Agents In Myeloid Disorders: Lower Doses Of Decitabine And Azacitidine Have Proven As Effective As Standard Dosing
99 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Should We Check If The Donor Has A Mutation: Depends On The Type Of Mutation, Not Every Mutation Is The Same
00:01:24

Should We Check If The Donor Has A Mutation: Depends On The Type Of Mutation, Not Every Mutation Is The Same
107 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Lenalidomide + Azacitidine Graft v Host
00:01:49

Lenalidomide + Azacitidine Graft v Host
60 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia
00:04:46

Combination Lenalidomide and Azacitidine: A Novel Salvage Therapy in Patients Who Relapse After Allogeneic Stem-Cell Transplantation for Acute Myeloid Leukemia
80 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways
00:52:19

Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways
363 Views
6 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Whats New In AML Transplants
00:00:43

Whats New In AML Transplants
49 Views
6 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Bladder Cancer

Seattle Genetics and Astellas Announce US FDA Grants Priority Review for Enfortumab Vedotin Biologics License Application in Locally Advanced or Metastatic Urothelial Cancer

Seattle Genetics and Astellas Announce US FDA Grants Priority Review for Enfortumab Vedotin Biologics License Application in Locally Advanced or Metastatic Urothelial Cancer
14 Views
5 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Mount Sinai Receives $1.7 million to Study Natural Killer Cell Dysfunction in Bladder Cancer

Mount Sinai Receives $1.7 million to Study Natural Killer Cell Dysfunction in Bladder Cancer
18 Views
1 week ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Strategies for Treating 2nd Line RCC Patients
00:01:17

Strategies for Treating 2nd Line RCC Patients
47 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Treating Newly Diagnosed RCC Patients
00:02:08

Treating Newly Diagnosed RCC Patients
49 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Data on Enfortumab in Post-Platinum and I-O Bladder Cancer
00:01:15

Data on Enfortumab in Post-Platinum and I-O Bladder Cancer
110 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Combo Ipilimumab + Nivolumab in Histologies of Bladder Cancer
00:01:28

Combo Ipilimumab + Nivolumab in Histologies of Bladder Cancer
49 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
TROPHY-u-01 Trial: A Phase II Open-Label Study Of Sacituzumab Govitecan (IMMU-132) In Patients With Advanced Urothelial Cancer
00:01:52

TROPHY-u-01 Trial: A Phase II Open-Label Study Of Sacituzumab Govitecan (IMMU-132) In Patients With Advanced Urothelial Cancer
171 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The Broad Implications of The SAUL Study
00:01:04

The Broad Implications of The SAUL Study
208 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The Challenges Using Biomarkers For Treatment Selection In Bladder Cancer
00:03:31

The Challenges Using Biomarkers For Treatment Selection In Bladder Cancer
52 Views
6 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The Role Of Checkpoint Inhibitors In Bladder Cancer
00:01:53

The Role Of Checkpoint Inhibitors In Bladder Cancer
91 Views
6 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Molecular Characterization & Subtyping Data In Bladder Cancer
00:01:39

Molecular Characterization & Subtyping Data In Bladder Cancer
101 Views
6 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The Latest In Screening For High-Risk Asymptomatic Bladder Cancer
00:01:53

The Latest In Screening For High-Risk Asymptomatic Bladder Cancer
140 Views
6 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Bone Metastases

If Practitioner Identifies Light-Chain Amyloidosis | Referring to Site Where Trial is Open is a Great Idea
00:00:40

If Practitioner Identifies Light-Chain Amyloidosis | Referring to Site Where Trial is Open is a Great Idea
190 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Brain Cancer

How does this affect clinicians today?
0:01:20

How does this affect clinicians today?
2 Views
4 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells
0:01:26

Targeting Metabolic Reprogramming to Radiosensitize Glioblastoma Stem Cells
3 Views
4 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Oncoceutics Commemorates National Childhood Cancer Awareness Month

Oncoceutics Commemorates National Childhood Cancer Awareness Month
4 Views
5 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Publication Reports Clinical Efficacy of ONC201 in Expanded Access H3 K27M-mutant Glioma Patients

Publication Reports Clinical Efficacy of ONC201 in Expanded Access H3 K27M-mutant Glioma Patients
10 Views
1 week ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Oncoceutics Announces FDA Acceptance of Investigational New Drug Application for Phase I Trial of ONC206

Oncoceutics Announces FDA Acceptance of Investigational New Drug Application for Phase I Trial of ONC206
24 Views
3 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Why Does This Subset Of Patients Respond To ONC201: It Appears To Be Very Effective In This Subset Of The Disease Because Its A Vulnerability Produced By This Mutation
00:00:56

Why Does This Subset Of Patients Respond To ONC201: It Appears To Be Very Effective In This Subset Of The Disease Because Its A Vulnerability Produced By This Mutation
152 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Other Suitable Combinations For This Agent That Could Help More People: Which Combination Makes The Most Sense For A Given Patient Will Depend On What Is Happening In Their Tumor
00:01:29

Other Suitable Combinations For This Agent That Could Help More People: Which Combination Makes The Most Sense For A Given Patient Will Depend On What Is Happening In Their Tumor
111 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Latest Data For Patients Treated With ONC201 With H3 K27M-Mutant Glioma: Median Onset Of Response Was 3 Months, Median Followup Of Slightly More Than 7 Months
00:02:04

Latest Data For Patients Treated With ONC201 With H3 K27M-Mutant Glioma: Median Onset Of Response Was 3 Months, Median Followup Of Slightly More Than 7 Months
346 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Latest Data On SurVaxM Vaccine: Doubled Progression Free Period, Patients Are Surviving About 30 Months On Vaccine, Standard Of Care Median Survival Of 15 Months
00:03:29

Latest Data On SurVaxM Vaccine: Doubled Progression Free Period, Patients Are Surviving About 30 Months On Vaccine, Standard Of Care Median Survival Of 15 Months
106 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Talazoparib First Line Treatment
00:01:14

Talazoparib First Line Treatment
126 Views
10 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
IMpassion130, Solar-1 Trial Data
00:02:56

IMpassion130, Solar-1 Trial Data
74 Views
10 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
GAPVAC-101: personalized vaccines for newly-diagnosed glioblastoma
00:03:38

GAPVAC-101: personalized vaccines for newly-diagnosed glioblastoma
169 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Breast Cancer

Standard Conversion Rate From Lumpectomy to Mastectomy
0:03:13

Standard Conversion Rate From Lumpectomy to Mastectomy
2 Views
1 day ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Reducing The Need For Second Surgery After Lumpectomy: How Will This Affect Data Today?
0:01:59

Reducing The Need For Second Surgery After Lumpectomy: How Will This Affect Data Today?
0 Views
1 day ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Reducing The Need For Second Surgery After Lumpectomy: Why Isn't Everybody Doing This?
0:02:47

Reducing The Need For Second Surgery After Lumpectomy: Why Isn't Everybody Doing This?
2 Views
2 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Intraoperative Teamwork of Breast Cancer Surgeon and Pathologist
0:02:20

Intraoperative Teamwork of Breast Cancer Surgeon and Pathologist
4 Views
2 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
CDK 4/6 Inhibitors in Treating Breast Cancer
00:01:39

CDK 4/6 Inhibitors in Treating Breast Cancer
235 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
MONALEESA-7 Trial Outcomes in Premenopausal Breast Cancer
00:02:00

MONALEESA-7 Trial Outcomes in Premenopausal Breast Cancer
66 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
SOPHIA Trial Outcomes
00:01:39

SOPHIA Trial Outcomes
101 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Efficacy and Safety of Combination Eribulin + Pembrolizumab
00:02:01

Efficacy and Safety of Combination Eribulin + Pembrolizumab
374 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
ImPassion130 Study Outcomes
00:01:54

ImPassion130 Study Outcomes
29 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
MONALEESA-7 Trial Outcomes
00:01:53

MONALEESA-7 Trial Outcomes
27 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Transition from Volume to Value
00:02:15

Transition from Volume to Value
125 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Cost Factors in Novel Therapeutic Interventions
00:01:31

Cost Factors in Novel Therapeutic Interventions
91 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Business Management

Two Sided Payment Agreements & The Risks Involved
00:01:47

Two Sided Payment Agreements & The Risks Involved
114 Views
8 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
MOASC COAnalyzer Tool Ricky Newton
01:01:00

MOASC COAnalyzer Tool Ricky Newton
98 Views
11 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Cervical Cancer

Novel revelations in CLL biology with venetoclax/ibrutinib
00:02:24

Novel revelations in CLL biology with venetoclax/ibrutinib
71 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Immunotherapy in gynecological cancers: current and future landscape
00:02:35

Immunotherapy in gynecological cancers: current and future landscape
473 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Chronic Lymphocytic Leukemia

ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia
00:04:47

ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia
200 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs
00:07:04

ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs
91 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
CLL, What is the significance of IGHV mutations and how are they assessed
00:02:48

CLL, What is the significance of IGHV mutations and how are they assessed
84 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Not Your Fathers CLL with Dr. John Pagel
01:02:14

Not Your Fathers CLL with Dr. John Pagel
110 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
CLL, Is there a role still for chemo AND who should get chemo
00:04:01

CLL, Is there a role still for chemo AND who should get chemo
72 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
CLL, FCR vs BR – Is One Better
00:04:22

CLL, FCR vs BR – Is One Better
172 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The Role of CAR-T Therapy in B-Cell Lymphomas
00:02:12

The Role of CAR-T Therapy in B-Cell Lymphomas
69 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Outcomes from RESONATE Trial in Relapsed CLL
00:01:54

Outcomes from RESONATE Trial in Relapsed CLL
67 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
CLL-14 Data Trial in Chronic Lymphocytic Leukemia
00:01:48

CLL-14 Data Trial in Chronic Lymphocytic Leukemia
148 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Opinion on Ibrutinib on 1st Line CLL
00:01:58

Opinion on Ibrutinib on 1st Line CLL
189 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The Importance of Minimal Residual Disease Negativity
00:01:04

The Importance of Minimal Residual Disease Negativity
65 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics
00:20:42

R/R High Risk CLL: Personalized Management Based on Patient Characteristics and Cytogenetics
162 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Chronic Myelogenous Leukemia

Treating CML & Myelofibrosis Patients
00:01:34

Treating CML & Myelofibrosis Patients
316 Views
8 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Resistance/intolerance to second generation TKIs in CML: what to do next?
00:02:14

Resistance/intolerance to second generation TKIs in CML: what to do next?
151 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Update on ENESTop: TFR in CML after discontinuing nilotinib
00:02:35

Update on ENESTop: TFR in CML after discontinuing nilotinib
125 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Benefits of second generation TKIs for CML in the frontline
00:01:45

Benefits of second generation TKIs for CML in the frontline
90 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Personalized therapy in leukemia: a case study
00:01:04

Personalized therapy in leukemia: a case study
235 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
New drugs for CML: are more to come?
00:00:37

New drugs for CML: are more to come?
60 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Bosutinib: a new, safer TKI for frontline CML
00:01:02

Bosutinib: a new, safer TKI for frontline CML
91 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Asciminib has the potential to succeed where other TKIs have failed in CML
00:00:57

Asciminib has the potential to succeed where other TKIs have failed in CML
207 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
DESTINY: achieving TFR by de-escalating therapy in CML
00:01:52

DESTINY: achieving TFR by de-escalating therapy in CML
95 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Novel agents or imatinib for CML in the frontline setting?
00:01:26

Novel agents or imatinib for CML in the frontline setting?
74 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Evolving treatment goals in CML
00:00:47

Evolving treatment goals in CML
77 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Updates in CML: recent trials and novel agents
00:01:18

Updates in CML: recent trials and novel agents
81 Views
1 year ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Colorectal Cancer

How does this affect treatment?
0:01:40

How does this affect treatment?
4 Views
3 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Is this truly safe?
0:02:25

Is this truly safe?
1 Views
3 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
0:03:38

Radiation Therapy in Patients with Inflammatory Bowel Disease and Rectal Cancer
6 Views
3 days ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
IDEA: Factors to consider
0:01:04

IDEA: Factors to consider
1 Views
3 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The impact the IDEA data will have on clinicians
0:00:48

The impact the IDEA data will have on clinicians
0 Views
3 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
IDEA: 3 vs. 6 months
0:01:33

IDEA: 3 vs. 6 months
1 Views
3 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The IDEA Collaboration
0:02:55

The IDEA Collaboration
2 Views
3 weeks ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Twitter Teaser - Pas-Arez - English Overview Lurbinectedin in Second-line SCLC
00:00:47

Twitter Teaser - Pas-Arez - English Overview Lurbinectedin in Second-line SCLC
4 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Value of Liquid Biopsy in CRC
00:04:23

Value of Liquid Biopsy in CRC
141 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Molecular Profiling in the Treatment of CRC
00:05:11

Molecular Profiling in the Treatment of CRC
162 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
APACT Trial in Pancreatic Adenocarcinoma
00:02:27

APACT Trial in Pancreatic Adenocarcinoma
145 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Changing the Way We Treat CRC
00:00:53

Changing the Way We Treat CRC
102 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login

Gastrointestinal Cancer

KEYNOTE-062: Pembrolizumab in HER2-, PD-L1 Positive Advanced Gastric Cancer
00:01:16

KEYNOTE-062: Pembrolizumab in HER2-, PD-L1 Positive Advanced Gastric Cancer
172 Views
2 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
When Do You Prescribe Bland Vs Chemo Or Radio Embolization: Chemo Embolization Has Not Caught On In Our Institution Because The Side Effects & Extra Months Of Durability Are Not Of Value
00:02:20

When Do You Prescribe Bland Vs Chemo Or Radio Embolization: Chemo Embolization Has Not Caught On In Our Institution Because The Side Effects & Extra Months Of Durability Are Not Of Value
215 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Inducing Embolization Syndrome When Performing infarction: Not Uncommon To Take 4-8 Weeks To Get Over The Treatment Of Embolotherapy
00:02:12

Inducing Embolization Syndrome When Performing infarction: Not Uncommon To Take 4-8 Weeks To Get Over The Treatment Of Embolotherapy
26 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Evaluating mTOR Inhibitor Everolimus With Embolotherapy: Objective Response Rate Of 57 We Did Not Stop Everolimus During Embolotherapy, We Continued It
00:01:57

Evaluating mTOR Inhibitor Everolimus With Embolotherapy: Objective Response Rate Of 57 We Did Not Stop Everolimus During Embolotherapy, We Continued It
125 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Caring For Every Patient And Learning From Every Patient
00:01:19

Caring For Every Patient And Learning From Every Patient
158 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
The Quality and Completeness of Data
00:00:43

The Quality and Completeness of Data
112 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Financial Toxicity and Equitable Access to Clinical Trials
00:01:22

Financial Toxicity and Equitable Access to Clinical Trials
63 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Safety Profile for Pembrolizumab
00:01:03

Safety Profile for Pembrolizumab
20 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Pembrolizumab with or without chemotherapy versus chemotherapy for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The phase III KEYNOTE-062 study.
00:02:43

Pembrolizumab with or without chemotherapy versus chemotherapy for advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: The phase III KEYNOTE-062 study.
77 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Combining Chemo & Immunotherapy Did Not Help Patients: Hope To See Survival Level Off As Data Matures
00:01:08

Combining Chemo & Immunotherapy Did Not Help Patients: Hope To See Survival Level Off As Data Matures
34 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Updates In Esophageal & Gastric Cancers: When Dose Of Xeloda & Oxaliplatin Is Reduced In Frail Patients They Did Very Well & Had Less Toxicity
00:01:34

Updates In Esophageal & Gastric Cancers: When Dose Of Xeloda & Oxaliplatin Is Reduced In Frail Patients They Did Very Well & Had Less Toxicity
29 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Lower Doses Of Xeloda & Oxaliplatin: Physicians Would Be Happy To Give A Lower Dose If Data Supports
00:00:50

Lower Doses Of Xeloda & Oxaliplatin: Physicians Would Be Happy To Give A Lower Dose If Data Supports
13 Views
3 months ago
Want to watch this again later?
Sign in to add this video to a playlist. Login